Adjuvant medical therapy to improve patency rate following reconstruction for atherosclerosis obliterans (ASO).
Lepäntalo
M
M
Fourth Department of Surgery, Helsinki University Central Hospital, Finland.
D000925:Anticoagulants / Q000627:therapeutic use*; D001162:Arteriosclerosis Obliterans / Q000601:surgery*; D001807:Blood Vessel Prosthesis; D002986:Clinical Trials as Topic; D006083:Graft Occlusion, Vascular / Q000517:prevention & control*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011453:Prostaglandins / Q000627:therapeutic use*; D014654:Vascular Patency
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D011453:Prostaglandins